eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search   

Letters

Health services research in Hungary

Imre Boncz and Andor Sebestyén
MJA 2006; 184 (12): 646-647

To the Editor: We read with great interest the editorial by Gruen and colleagues on the recent developments in health services research and the establishment of an EPOC (Effective Practice and Organisation of Care) satellite at the National Institute of Clinical Studies in Australia.1

Before the social and political changes in Central and Eastern Europe in the 1990s, policymakers in Hungary (population 10 million) and many other former socialist countries had little interest in the effectiveness of health service interventions.2 Important tools of health policy decision making were missing from the health care system. Over the past 16 years, efforts have been made in Hungary to strengthen the institutional background and tools of health policy decision making. We would like to highlight some milestones of this process.

During the 1990s, Hungarian researchers were sent to foreign universities to receive formal training in subjects related to health services research. Later, academic institutions and departments were established (Health Services Management Training Centre at Semmelweis University [Budapest], School of Public Health at the University of Debrecen [eastern Hungary], Unit of Health Economics and Health Technology Assessment at Corvinus University [Budapest], and Department of Health Insurance and Health Policy at the University of Pécs [southern Hungary]).

In 2004, the National Institute for Strategic Health Research was established to guide governmental health policy decision making by undertaking activities in four main areas: health informatics and information policy; health economics; health services and health system research; and health technology assessment and coverage policy. A key issue of Hungarian health policy was the introduction of the “fourth hurdle” (cost-effectiveness) into the decision-making process.3 In a first step towards achieving this, methodology standards were published by the Ministry of Health, which regulates the guidelines for conducting economic evaluation.4,5

During the development of health services research in Hungary, we carefully studied many aspects of the Australian experience, published in the international literature or presented at scientific meetings, including: coverage policy, drug pricing and reimbursement, health technology assessment, price/volume agreements, diagnosis-related groups, evidence-based guidelines, the National Health and Medical Research Council, the Pharmaceutical Benefits Advisory Committee and the Pharmaceutical Benefits Scheme, and performance measurement. Several of these (coverage policy, drug pricing and reimbursement, and diagnosis-related groups) had a significant effect on Hungarian health policy decision making.

We found the main advantages of the Australian system, compared with other countries, to be the strong scientific and professional background (evidence-based medicine) and the transparency of decision making. Although we did not make any formal ranking of countries, the Australian experiences were evaluated as worthwhile for local application, together with those of the Netherlands, Sweden and the United Kingdom.

Notwithstanding the considerable distance between Australia and Hungary, we look forward to reading about further developments in health services research and the Australian EPOC satellite, and hope that we can also benefit from your experience with the appropriate implementation of research findings throughout health policy decision making and into everyday medical practice.

Imre Boncz, Department Head1Andor Sebestyén, Deputy Director2

1 Department of Health Policy, National Health Insurance Fund Administration (OEP), Budapest, Hungary.

2 County Baranya Health Insurance Fund Administration, National Health Insurance Fund Administration (OEP), Pécs, Hungary.

boncz.iAToep.hu

  1. Gruen RL, Buchan H, Davies J, et al. A new EPOC in Australian health research [editorial]. Med J Aust 2006; 184: 4-5. <eMJA full text> <PubMed>
  2. Boncz I, Klazinga N, Rutten F. East-West life expectancy and health expenditure gap in Europe: a case study from behind the iron curtain. Presented at the 32nd Annual Conference of the Public Health Association of Australia; 2000 Nov 26-29; Canberra.
  3. Gulacsi L, Boncz I, Drummond M. Issues for countries considering introducing the “fourth hurdle”: the case of Hungary. Int J Technol Assess Health Care 2004; 20: 337-341. <PubMed>
  4. Szende A, Mogyorosy Z, Muszbek N, et al. Methodological guidelines for conducting economic evaluation of healthcare interventions in Hungary: a Hungarian proposal for methodology standards. Eur J Health Econ 2002; 3: 196-202.
  5. Gulacsi L, David T, Dozsa C. Pricing and reimbursement of drugs and medical devices in Hungary. Eur J Health Econ 2002; 3: 271-278. <PubMed>

(Received 2 Mar 2006, accepted 4 May 2006)

Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA  

©The Medical Journal of Australia 2006 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377